| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 5, 1806-1814, Copyright © 1991 by Endocrine Society
ARTICLES |
KA Houck, N Ferrara, J Winer, G Cachianes, B Li and DW Leung
Department of Molecular Biology, Genetech, Inc., South San Francisco, California 94080.
Vascular endothelial growth factor (VEGF) was recently identified as a secreted, direct-acting mitogen specific for vascular endothelial cells and capable of stimulating angiogenesis in vivo. Molecular cloning revealed multiple forms of VEGF, apparently arising from alternative splicing of its RNA transcript. We have examined various human cDNA libraries by the polymerase chain reaction technique and discovered a fourth molecular form, VEGF206. This form contains a 41-amino acid insertion relative to the most abundant form, VEGF165, and includes the highly basic 24-amino acid insertion found in VEGF189. Southern blot analysis revealed that a single gene encoded these various forms, and nucleic acid sequence analysis of a portion of the VEGF gene revealed an intron/exon structure compatible with alternative splicing of RNA as a mechanism for their generation. Transient transfection of human embryonic kidney 293 cells showed that, like VEGF189, VEGF206 was predominately cell-associated and only very poorly secreted despite the presence of the signal peptide identical to that found in VEGF121 and VEGF165, both of which are efficiently exported from the cell. Vascular permeability activity was detected in the medium of 293 cells transfected with all four forms of VEGF; however, endothelial cell mitogenic activity was apparent only with VEGF121 and VEGF165. Thus, alternative splicing of VEGF RNA can produce four polypeptides with strikingly different secretion patterns, which suggests multiple physiological roles for this family of proteins.
This article has been cited by other articles:
 |
|
 |
|
  G. H. Kim, D. K. Hahn, C. P. Kellner, Z. L. Hickman, R. J. Komotar, R. M. Starke, W. J. Mack, J. Mocco, R. A. Solomon, and E. S. Connolly Jr Plasma Levels of Vascular Endothelial Growth Factor After Treatment for Cerebral Arteriovenous Malformations Stroke, August 1, 2008; 39(8): 2274 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-L. Wang, X.-P. Xu, B.-L. He, S.-P. Weng, J. Xiao, L. Wang, T. Lin, X. Liu, Q. Wang, X.-Q. Yu, et al. Infectious Spleen and Kidney Necrosis Virus ORF48R Functions as a New Viral Vascular Endothelial Growth Factor J. Virol., May 1, 2008; 82(9): 4371 - 4383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kowanetz and N. Ferrara Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 173 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Weinzierl, D. Maurer, F. Altenberend, N. Schneiderhan-Marra, K. Klingel, O. Schoor, D. Wernet, T. Joos, H.-G. Rammensee, and S. Stevanovic A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays Cancer Res., April 1, 2008; 68(7): 2447 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bastide, Z. Karaa, S. Bornes, C. Hieblot, E. Lacazette, H. Prats, and C. Touriol An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform Nucleic Acids Res., April 1, 2008; 36(7): 2434 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Qiu, H. Bevan, S. Weeraperuma, D. Wratting, D. Murphy, C. R Neal, D. O. Bates, and S. J. Harper Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b FASEB J, April 1, 2008; 22(4): 1104 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mineur, A. C. Colige, Christophe. F. Deroanne, J. Dubail, F. Kesteloot, Y. Habraken, A. Noel, S. Voo, J. Waltenberger, C. M. Lapiere, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents J. Cell Biol., December 17, 2007; 179(6): 1261 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Donnem, S. Al-Saad, K. Al-Shibli, M. P. Delghandi, M. Persson, M. N. Nilsen, L.-T. Busund, and R. M. Bremnes Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non Small Cell Lung Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6649 - 6657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification J. Dent. Res., October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gridelli, P. Maione, A. Rossi, and F. De Marinis The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments Oncologist, October 1, 2007; 12(10): 1183 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain J. Biol. Chem., September 21, 2007; 282(38): 28045 - 28056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Pan, Y. Chathery, Y. Wu, N. Rathore, R. K. Tong, F. Peale, A. Bagri, M. Tessier-Lavigne, A. W. Koch, and R. J. Watts Neuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting J. Biol. Chem., August 17, 2007; 282(33): 24049 - 24056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zygalaki, E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou Quantitative Real-Time Reverse Transcription PCR Study of the Expression of Vascular Endothelial Growth Factor (VEGF) Splice Variants and VEGF Receptors (VEGFR-1 and VEGFR-2) in Non Small Cell Lung Cancer Clin. Chem., August 1, 2007; 53(8): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-S. Hwang, S.-W. Wang, W.-M. Tseng, C.-H. Yu, and P. S. Wang Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1763 - E1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Lake, R. Vassy, M. Di Benedetto, D. Lavigne, C. Le Visage, G. Y. Perret, and D. Letourneur Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1 J. Biol. Chem., December 8, 2006; 281(49): 37844 - 37852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells Am. J. Pathol., November 1, 2006; 169(5): 1753 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kowanetz and N. Ferrara Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective Clin. Cancer Res., September 1, 2006; 12(17): 5018 - 5022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Choi, K.-B. Kim, W. Han, D. S. Kim, J. S. Park, J. J. Lee, and D. S. Lee Efficacy of Therapeutic Angiogenesis by Intramyocardial Injection of pCK-VEGF165 in Pigs Ann. Thorac. Surg., August 1, 2006; 82(2): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. van de Langerijt, J. M. Gijtenbeek, H.P.M. de Reus, F. C.G.J. Sweep, A. Geurts-Moespot, J. C.M. Hendriks, A. C. Kappelle, and M. M. Verbeek CSF levels of growth factors and plasminogen activators in leptomeningeal metastases. Neurology, July 11, 2006; 67(1): 114 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Saint-Geniez, A. E. Maldonado, and P. A. D'Amore VEGF Expression and Receptor Activation in the Choroid during Development and in the Adult. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3135 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Morabito, E. De Maio, M. Di Maio, N. Normanno, and F. Perrone Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions Oncologist, July 1, 2006; 11(7): 753 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jia, A. Bagherzadeh, B. Hartzoulakis, A. Jarvis, M. Lohr, S. Shaikh, R. Aqil, L. Cheng, M. Tickner, D. Esposito, et al. Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling J. Biol. Chem., May 12, 2006; 281(19): 13493 - 13502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Glass, S. J. Harper, and D. O. Bates The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo J. Physiol., April 1, 2006; 572(1): 243 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Yance Jr and S. M. Sagar Targeting angiogenesis with integrative cancer therapies. Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29. [Abstract] [PDF]
|
|
|
|
|
|
C. J. Robinson, B. Mulloy, J. T. Gallagher, and S. E. Stringer VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase J. Biol. Chem., January 20, 2006; 281(3): 1731 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Rouet, Y. Hamma-Kourbali, E. Petit, P. Panagopoulou, P. Katsoris, D. Barritault, J.-P. Caruelle, and J. Courty A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis J. Biol. Chem., September 23, 2005; 280(38): 32792 - 32800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zygalaki, A. Stathopoulou, C. Kroupis, L. Kaklamanis, Z. Kyriakides, D. Kremastinos, and E. S. Lianidou Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants Clin. Chem., August 1, 2005; 51(8): 1518 - 1520. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gustafsson, H. Ameln, H. Fischer, C. J. Sundberg, J. A. Timmons, and E. Jansson VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise J Appl Physiol, June 1, 2005; 98(6): 2137 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lee, S. M. Jilani, G. V. Nikolova, D. Carpizo, and M. L. Iruela-Arispe Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J. Cell Biol., May 23, 2005; 169(4): 681 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-F. Wang, J. Z. Cui, S. S. Prasad, and J. A. Matsubara Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1508 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Podar and K. C. Anderson The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications Blood, February 15, 2005; 105(4): 1383 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Pollard, S. Quan, T. Kang, and R. J. Koch Effects of Copper Tripeptide on the Growth and Expression of Growth Factors by Normal and Irradiated Fibroblasts Arch Facial Plast Surg, January 1, 2005; 7(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Woolard, W.-Y. Wang, H. S. Bevan, Y. Qiu, L. Morbidelli, R. O. Pritchard-Jones, T.-G. Cui, M. Sugiono, E. Waine, R. Perrin, et al. VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant: Mechanism of Action, In vivo Effect On Angiogenesis and Endogenous Protein Expression Cancer Res., November 1, 2004; 64(21): 7822 - 7835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chen, Y. Kasama, J. S. Lee, B. Jim, M. Marin, and F. N. Ziyadeh Podocyte-Derived Vascular Endothelial Growth Factor Mediates the Stimulation of {alpha}3(IV) Collagen Production by Transforming Growth Factor-{beta}1 in Mouse Podocytes Diabetes, November 1, 2004; 53(11): 2939 - 2949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Castro-Rivera, S. Ran, P. Thorpe, and J. D. Minna Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect PNAS, August 3, 2004; 101(31): 11432 - 11437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jensen, H. Pilegaard, P. D. Neufer, and Y. Hellsten Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R397 - R402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Bond, L. J. Parry, C. S. Samuel, H. M. Gehring, F. L. Lederman, P. A. W. Rogers, and R. J. Summers Increased Expression of the Relaxin Receptor (LGR7) in Human Endometrium during the Secretory Phase of the Menstrual Cycle J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3477 - 3485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Friehs, A. M. Moran, C. Stamm, Y.-H. Choi, D. B. Cowan, F. X. McGowan, and P. J. del Nido Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury Ann. Thorac. Surg., June 1, 2004; 77(6): 2004 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Chung, Y. Song, Y. Wang, R. R. Magness, and J. Zheng Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2484 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bornes, M. Boulard, C. Hieblot, C. Zanibellato, J. S. Iacovoni, H. Prats, and C. Touriol Control of the Vascular Endothelial Growth Factor Internal Ribosome Entry Site (IRES) Activity and Translation Initiation by Alternatively Spliced Coding Sequences J. Biol. Chem., April 30, 2004; 279(18): 18717 - 18726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Asosingh, H. De Raeve, E. Menu, I. Van Riet, E. Van Marck, B. Van Camp, and K. Vanderkerken Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity Blood, April 15, 2004; 103(8): 3131 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Konecny, Y. G. Meng, M. Untch, H.-J. Wang, I. Bauerfeind, M. Epstein, P. Stieber, J.-M. Vernes, J. Gutierrez, K. Hong, et al. Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients Clin. Cancer Res., March 1, 2004; 10(5): 1706 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz, C. Pettaway, R. Song, O. Stoeltzing, L. Ellis, and M. Bar-Eli Activator Protein 2{alpha} Inhibits Tumorigenicity and Represses Vascular Endothelial Growth Factor Transcription in Prostate Cancer Cells Cancer Res., January 15, 2004; 64(2): 631 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gogat, L. Le Gat, L. Van Den Berghe, D. Marchant, A. Kobetz, S. Gadin, B. Gasser, I. Quere, M. Abitbol, and M. Menasche VEGF and KDR Gene Expression during Human Embryonic and Fetal Eye Development Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jiang and J. R. Couchman Perlecan and Tumor Angiogenesis J. Histochem. Cytochem., November 1, 2003; 51(11): 1393 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Huang, F.-M. Tang, Y.-H. Huang, I-H. Liu, S.-C. Hsu, S.-T. Chen, and J. S. Huang Cloning, Expression, Characterization, and Role in Autocrine Cell Growth of Cell Surface Retention Sequence Binding Protein-1 J. Biol. Chem., October 31, 2003; 278(44): 43855 - 43869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, L. H. Cheung, P. Thorpe, and M. G. Rosenblum Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells Mol. Cancer Ther., October 1, 2003; 2(10): 949 - 959. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Shimizu, J.-Y. Jiang, K. Iijima, K. Miyabayashi, Y. Ogawa, H. Sasada, and E. Sato Induction of Follicular Development by Direct Single Injection of Vascular Endothelial Growth Factor Gene Fragments into the Ovary of Miniature Gilts Biol Reprod, October 1, 2003; 69(4): 1388 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.A. Roopa, A. Loganath, and K. Singh The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Stoeltzing, W. Liu, N. Reinmuth, A. Parikh, S. A. Ahmad, Y. D. Jung, F. Fan, and L. M. Ellis Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis Ann. Surg. Oncol., August 1, 2003; 10(7): 722 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mata-Greenwood, B. Meyrick, S. J. Soifer, J. R. Fineman, and S. M. Black Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L222 - L231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Turcotte, R. R. Desrosiers, and R. Beliveau HIF-1{alpha} mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma J. Cell Sci., June 1, 2003; 116(11): 2247 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Louzier, B. Raffestin, A. Leroux, D. Branellec, J. M. Caillaud, M. Levame, S. Eddahibi, and S. Adnot Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L926 - L937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Foster, R. Hole, K. Anderson, S. C. Satchell, R. J. Coward, P. W. Mathieson, D. A. Gillatt, M. A. Saleem, D. O. Bates, and S. J. Harper Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1263 - F1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lange, N. Guttmann-Raviv, L. Baruch, M. Machluf, and G. Neufeld VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human Cells J. Biol. Chem., May 2, 2003; 278(19): 17164 - 17169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sonoda, M. Kanamori, D. F. Deen, S.-Y. Cheng, M. S. Berger, and R. O. Pieper Overexpression of Vascular Endothelial Growth Factor Isoforms Drives Oxygenation and Growth but not Progression to Glioblastoma Multiforme in a Human Model of Gliomagenesis Cancer Res., April 15, 2003; 63(8): 1962 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.C Felmeden, A.D Blann, and G.Y.H Lip Angiogenesis: basic pathophysiology and implications for disease Eur. Heart J., April 1, 2003; 24(7): 586 - 603. [Full Text] [PDF]
|
|
|
|
|
|
C. Benckert, S. Jonas, T. Cramer, Z. von Marschall, G. Schafer, M. Peters, K. Wagner, C. Radke, B. Wiedenmann, P. Neuhaus, et al. Transforming Growth Factor {beta}1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells Cancer Res., March 1, 2003; 63(5): 1083 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. YIN, Z. SALAH, M. MAOZ, S. C. E. RAM, S. OCHAYON, G. NEUFELD, S. KATZAV, and R. BAR-SHAVIT Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation FASEB J, February 1, 2003; 17(2): 163 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 |
